| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.9M | -33.1% |
| Cost of Revenue | $3.6M | -27.0% |
| Gross Profit | $3.3M | -38.7% |
| R&D Expense | $7.2M | -30.5% |
| SG&A Expense | $9.4M | -31.9% |
| Operating Income | -$19.4M | +44.6% |
| Interest Expense | $773K | -32.7% |
| Net Income | -$13.1M | +63.7% |
| EPS (Basic) | $5.06 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | +71.1% |
| Current Assets | $3.5M | -13.0% |
| Total Assets | $9.8M | -48.4% |
| Current Liabilities | $7.6M | -43.0% |
| Total Liabilities | $7.7M | -54.9% |
| Stockholders' Equity | $3.0M | +98.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.9M | +33.8% |
| Capital Expenditures | $32K | -89.2% |
| Investing Cash Flow | $4.2M | +1539.9% |
| Financing Cash Flow | $9.9M | +480.1% |
| Free Cash Flow | -$12.9M | +34.6% |
| +116.5% |
| EPS (Diluted) | $5.06 | -83.5% |